Computer-assisted bilingual vocabulary help for kids with language disorder
Official title: A Randomized Controlled Trial of Computer-Assisted Bilingual Vocabulary Intervention in Emergent Bilinguals with Developmental Language Disorder
Funded at Texas Christian University · NIH-11346956 · Data updated 2026-11-12
A computer-assisted program helps monolingual clinicians teach bilingual Spanish-English vocabulary to emergent bilingual children with developmental language disorder.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Christian University NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | May 15, 2026 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $530,054 |
| NIH project number | 1R01DC023613-01 |
| Project ID | NIH-11346956 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children aged 0-11 with developmental language disorder who are emergent bilingual Spanish-English speakers and have limited access to bilingual speech-language pathology services.
✕Less likely to help
Children outside the target age range or without DLD, or those who already have ready access to bilingual clinicians, may not benefit.
What this research studies
This project tests a technology-driven method called CABVI that guides clinicians to deliver bilingual Spanish–English vocabulary lessons. It uses interactive, responsive content to support dual-language development without losing English skills. The study will compare the CABVI approach to standard care in a randomized trial to see if it improves language outcomes in both languages and fits real-world clinical settings. If successful, CABVI could make bilingual services more accessible for children with DLD who speak Spanish at home. The work is designed to be scalable so more clinics can provide effective bilingual intervention in diverse communities.
Why it matters
Potential benefit: If proven effective, CABVI could increase access to high-quality bilingual language therapy for emergent bilingual children with DLD, reducing long-term language disparities.
How similar studies have gone: Previous bilingual interventions show promise, and this study tests a scalable, technology-assisted approach in a rigorous trial.
Where this research is happening
-
Texas Christian University
Fort Worth, United States Active
Researchers
- Principal investigator: Rivera Perez, Jean F — Texas Christian University
- Study coordinator: Rivera Perez, Jean F
Related research
Other NIH-funded projects on the same topics.
-
Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure
A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.